<p><sup>a</sup> Last total cholesterol value measured in each specified time window prior to the index date of colorectal cancer diagnosis. <sup>b</sup> Adjusted for obesity (BMI ≥ 30 kg/m<sup>2</sup>), ever smoking, chronic use of aspirin or NSAIDs, hormone replacement therapy, alcohol consumption, diabetes mellitus, performance of bowel screening, and non-statin cholesterol-lowering medication. <sup>c</sup> Per 1 mmol/L increase in serum total cholesterol.</p
Background: Dyslipidemia is an established risk factor for many diseases, but its effect on colorect...
International audienceAIM: To examine the relationships between pre-diagnostic biomarkers and colore...
Dyslipidemia and statin use have been associated with colorectal cancer (CRC), but prospective studi...
Several prior studies have found an association between statin use and reduced risk of colorectal ca...
A reductase inhibitors, commonly known as statins, account for most cho-lesterol-lowering drug use i...
The anticarcinogenic effect of statins may reduce the metastatic potential of cancer cells leading t...
Objective To examine the association between serum concentrations of total cholesterol, high density...
IntroductionColorectal cancer(CRC) is 3rd most common cancer and has a relatively high mortality rat...
OBJECTIVE: To examine the association between serum concentrations of total cholesterol, high densit...
[[abstract]]AIM: T0 investigate whether the use of statins is associated with colorectal cancer risk...
(1) Background: The pleiotropic effects of statins may explain a chemoprotective action against colo...
Background: Statins are the backbone of lipid-lowering therapy and are among the most commonly presc...
Statins have been associated with a decreased cancer mortality. However, cholesterol level as such m...
Background: Dyslipidemia is an established risk factor for many diseases, but its effect on colorect...
Background: Dyslipidemia is an established risk factor for many diseases, but its effect on colorect...
International audienceAIM: To examine the relationships between pre-diagnostic biomarkers and colore...
Dyslipidemia and statin use have been associated with colorectal cancer (CRC), but prospective studi...
Several prior studies have found an association between statin use and reduced risk of colorectal ca...
A reductase inhibitors, commonly known as statins, account for most cho-lesterol-lowering drug use i...
The anticarcinogenic effect of statins may reduce the metastatic potential of cancer cells leading t...
Objective To examine the association between serum concentrations of total cholesterol, high density...
IntroductionColorectal cancer(CRC) is 3rd most common cancer and has a relatively high mortality rat...
OBJECTIVE: To examine the association between serum concentrations of total cholesterol, high densit...
[[abstract]]AIM: T0 investigate whether the use of statins is associated with colorectal cancer risk...
(1) Background: The pleiotropic effects of statins may explain a chemoprotective action against colo...
Background: Statins are the backbone of lipid-lowering therapy and are among the most commonly presc...
Statins have been associated with a decreased cancer mortality. However, cholesterol level as such m...
Background: Dyslipidemia is an established risk factor for many diseases, but its effect on colorect...
Background: Dyslipidemia is an established risk factor for many diseases, but its effect on colorect...
International audienceAIM: To examine the relationships between pre-diagnostic biomarkers and colore...
Dyslipidemia and statin use have been associated with colorectal cancer (CRC), but prospective studi...